Abstract: While β-catenin has been demonstrated as an essential molecule and therapeutic target for various cancer stem cells (CSCs) including those driven by MLL-fusions, here we show that transcriptional-memory from cells-of-origin predicts AML patient survival and allows β-catenin independent transformation in MLLCSCs-derived from hematopoietic stem cells (HSCs)-enriched LSK population but not myeloid-granulocyte progenitors. Mechanistically, β-catenin regulates expression of downstream targets of a key transcriptional-memory gene, Hoxa9 that is highly enriched in LSK-derived MLL-CSCs and helps sustain leukemic self-renewal. Suppression of Hoxa9 sensitizes LSK-derived MLL-CSCs to β-catenin inhibition resulting in abolishment of CSC transcriptional program and transformation ability. In addition, further molecular and functional analyses identified Prmt1 as a key common downstream mediator for β-catenin/Hoxa9 functions in LSK-derived MLLCSCs. Together, these findings not only uncover an unexpectedly important role of cells-of-origin transcriptional memory in regulating CSC self-renewal, but also reveal a novel molecular network mediated by β-catenin/Hoxa9/Prmt1 in governing leukemic self-renewal.
Introduction
Self-renewal is a critical feature of stem cells, but is diminshed upon differentiation into their progenitors.
During the differentiation process, gene expression programs responsible for self-renewal are downregulated, and frequently replaced by lineage specific transcriptional programs. Increasing evidence suggest that genes involved in promoting normal stem cell self-renewal are commonly hijacked in cancer stem cells (CSCs), which are believed to sustain the disease and be responsible for relapse of various cancers including acute myeloid leukemia (AML) (Fung, Leung et al., 2013 , Zeisig, Kulasekararaj et al., 2012 . Among them, one of the most striking molecules is β-catenin, which is required for leukemic stem cells (LSCs) driven by MLL-fusion proteins or their downstream targets, Meis1/Hoxa9 (Wang, Krivtsov et al., 2010 , Yeung, Esposito et al., 2010 .
Suppression of β-catenin reversed MLL-LSC to pre-LSC stage (Yeung et al., 2010) , and its complete inactivation prevented development of leukemia driven by MLLfusions or Meis1/Hoxa9 (Wang et al., 2010 , Yeung et al., 2010 . While β-catenin is critical for embryonic and a number of somatic stem cells including fetal hematopoietic stem cells (HSCs) (Malhotra & Kincade, 2009 , Zhao, Blum et al., 2007 , it is largely dispensable for adult HSCs, which can function normally when β-catenin alone or even together with γ-catenin are deleted (Cobas, Wilson et al., 2004 , Jeannet, Scheller et al., 2008 , Koch, Wilson et al., 2008 , highlighting the therapeutic potentials of targeting β-catenin for eradication of LSCs.
In spite of the fundamental difference between stem cells and their progenitors in self-renewal ability, others and we have shown that phenotypically and genetically indistinguishable cancers, including MLL-rearranged leukemia, can arise from not only stem cells, but also their immediate downstream short-lived progenitors with distinctive transcriptional programs (Blanpain, 2013 , Huntly, Shigematsu et al., 2004 , Krivtsov, Twomey et al., 2006 , So, Karsunky et al., 2003 , Visvader, 2011 . Consistently, gene expression signatures associated with stem cells and progenitors correlate with different clinical outcomes in AML (Eppert, Takenaka et al., 2011 , Krivtsov, Figueroa et al., 2013 . MLL leukemia derived from mouse HSCs enriched Lin -Sca1 + ckit + (LSK) populations can be more aggressive and less responsive to standard chemotherapy than those derived from granulocyte-myeloid progenitors (GMPs) (Krivtsov et al., 2013) . In line with this, a more recent study also reveals that HSC-derived leukemia drives an invasive EMT-related gene expression program, which may partly account for the aggressive nature of the disease (Stavropoulou, Kaspar et al., 2016) . In spite of these recent evidence indicating the importance of cancer cells-of-origin in disease pathogenesis, we still do not know if and how they may govern the ultilization of molecular pathways for selfrenewal, which is a defining feature of CSC and has been a major focus for development of effective cancer therapeutics in the past decade.
Given the important function of β-catenin in CSC biology, we carried out detailed functional biology and molecular studies examining β-catenin requirement in MLL-CSCs originated from different cells-of-origin. Here we report that transcriptional-memory from cells-of-origin that robustly predicts AML patient survival can govern and help to override the β-catenin requirement in MLL-CSCs.
Mechanistically, we identify a novel transcriptional network mediated by
Hoxa9/Prmt1 in sustaining leukemic self-renewal in the absence of β-catenin in HSCs-derived MLL-CSCs. These findings reveal previously unrecognized functions and molecular networks from cancer cells-of-origin that allow override of β-catenin dependent leukemic self-renewal, adding a new dimension to the ongoing research efforts in developing effective therapeutics for eradication of CSCs.
Results

LSK-but not GMPs-derived MLL-CSCs can override β-catenin requirements for leukemic self-renewal
To determine the functional requirement of β-catenin in MLL-CSCs derived from different cells-of-origin, we employed the previously described retroviral transduction/transformation assays (RTTA) (Yeung & So, 2009 , Zeisig & So, 2009 using HSCs-enriched Lin Appendix figure S1I, J), which readout the self-renewal property of CSCs and indicate the largely uncompromised CSC property in the absence of β-catenin in LSK-derived but not GMPs-derived MLL-CSCs. The results could also be reproduced using a different MLL-ENL construct carrying the minimal transformation domain (Slany, Lavau et al., 1998) and MLL-AF9 (Smith, Yeung et al., 2011) , and
were not due to different expression levels of the MLL fusions in these populations (Appendix figure S1K-M).
To gain further insights into the role of β-catenin in disease development, we followed the in vivo kinetics of the MLL transformed cells derived from different cellular origins with or without β-catenin. The results showed a similar percentage of engraftment across all samples of different cellular origins and genotypes at 16 and 96 hours post transplant ( Figure 1I ), suggesting that β-catenin deletion did not significantly affect homing and early in vivo proliferation abilities. In contrast to LSK-derived MLL-CSCs that continued to expand and induced leukemia in the absence of β-catenin, the expansion of GMP-MLL-ENL Ctnnb1 del/del cells slowed down at 15 days and were gradually lost in vivo over a 4-months period ( Figure 1I ), consistent with an impaired self-renewal.
β-catenin is also not required for leukemia maintenance by LSK-derived MLL-
CSCs
To explore the function of β-catenin in the maintenance of leukemia derived from different origin-specific CSCs, full-blown leukemic cells harvested from primary leukemic mice carrying Ctnnb1-floxed alleles were then treated with either EtOH or tamoxifen prior to transplantation into secondary recipients ( Figure 1A ). As expected, both EtOH-treated LSK-and GMPs-derived MLL leukemic cells could competently induce leukemia. Inactivation of β-catenin in GMP-MLL-ENL totally abolished their leukemogenic potential ( Figure 1J ), while β-catenin deficient LSK-MLL-ENL still efficiently induced leukemia and even with a slightly shorter latency in secondary recipients ( Figure 1K ). In contrast to the absolute requirement of β-catenin for development of various LSCs (Wang et al., 2010 , Yeung et al., 2010 , Zhao et al., 2007 , the finding of largely dispensable function of β-catenin in LSK-derived MLL-CSCs reveals an unexpected and previously unrecognized role of cells-of-origin in governing leukemic self-renewal for both cancer initiation and maintenance.
Genomic variations do not account for contrasting β-catenin dependence in
MLL-CSCs from different cells-of-origin
To assess if the observed cell-type specific differences could be explained by random genetic changes associated with particular cell types, nucleotide variations were called from all actively transcribed genes using RNA-Seq. Among 23,766,084 high quality base pairs (depth≥10 and quality≥30), the vast majority of sites (23, 747, 763) were invariant in all our primary cell lines, and identical to the reference genome GRCm38, while a very small proportion, 4663 SNPs (single nucleotide polymorphisms) were invariant and different from GRCm38. In depth variance analysis revealed that the difference between the LSK-MLL-ENL and GMP-MLL-ENL cells was not larger than between normal cells ( Figure 2A , Dataset EV1A-C), and there were no fixed differences between the samples that could have caused the observed phenotypic differences. Figure 2B , Dataset EV1C). Interestingly, the distribution of SNPs differing between cell types or mice was comparable for both comparisons in noncoding and coding regions (Appendix figure S2A) . Consistently, SNPs in coding regions occurred in similar proportions in exon, intron and UTR regions in both comparisions (Appendix figure S2B) . Moreover, the number of derived SNPs in GMP-MLL-ENL (9309) was higher than those in LSK-MLL-ENL cells (7916) showing CNV between same cell types (i.e., LSK-MLL-ENL vs GMP-MLL-ENL), whereas multiple chromosomal regions of about 50kb exhibiting CNV were detected between samples (i.e., mouse Exp60 vs mouse Expt69 in Dataset EV1D).
Importantly, there is also no known coding gene in the 1kb CNV region shared between cell types ( Figure 2D ), consistently indicating insignificant genomic difference between LSK-MLL-ENL vs GMP-MLL-ENL cells which could accout for their contrasting β-catenin dependence. Together, this data reveals relatively few genomic variation in LSK-MLL-ENL compared with GMP-MLL-ENL and the controls, suggesting that non-genomic influence from the cells-of-origin can be a key factor in governing the self-renewal property of genetically and phenotypically indistinguishable cancers.
Transcriptional memory from cells-of-origin governs self-renewal pathways and predicts AML patient survival
As self-renewal in normal stem cells is maintained by specific transcriptional programs, we hypothesized that the transcriptional memories from LSK and GMPs would be partially preserved even after transformation, resulting in transcriptional and functional differences observed in the respective CSCs (Zeisig et al., 2012 (Eppert et al., 2011) and MLL leukemic-GMP (LGMP) signatures from different cells-of-origin (Krivtsov et al., 2013) , the current transcriptional memory signature represents a stronger predictor to stratify patients into different prognostic subgroups based on both resultant median survivals and p-values (Appendix figure S2J ). Moreover, multivariate analyses consistently resulted in significant Cox proportional hazards ratios >1; z-score < 0.1 with both human HSC signature and transcriptional memory signature (Dataset EV2F). Together, these data indicate functional and pathological relevance of the newfound cells-of-origin transcriptional memory in governing human cancer biology beyond known cytogenetic/genetic risk factors.
Hoxa9 as a key transcriptional memory gene phenocopies β-catenin function in development of origin-specific MLL leukemia
Given the largely dispensable function of β-catenin in LSK-derived MLLCSCs, we hypothesize that some self-renewal programs from normal stem cells may persist after transformation, and can sustain self-renewal in the absence of β-catenin.
In the transcriptional-memory signature, there were a small number of self-renewal genes such as Hoxa9, Hoxa10 and Meis1 ( Figure 2E , F), which are known downstream targets of MLL fusions (Huang, Sitwala et al., 2012 , Milne, Briggs et al., 2002 , Zeisig, Milne et al., 2004 
Suppression of Hoxa9 abolishes β-catenin independent transformation in LSKderived MLL-CSCs
To gain further molecular insights into the functional interplay between β-catenin and Hoxa9 in mediating self-renewal in origin-specific CSCs, we generated a novel compound Hoxa9 and Appendix figure S4H ), consistent with a critical functional crosstalk between Hoxa9 and β-catenin, in which a high level of Hoxa9 expression allows β-catenin independent transformation in LSK-derived MLL-CSCs.
β-catenin and Hoxa9 co-regulate Prmt1 in LSK-MLL-ENL cells
To gain further insights into the molecular pathways underlying β-catenin and Hoxa9 mediated leukemic self-renewal, we sought to define common gene sets that were deregulated upon the loss of leukemic self-renewal (i.e., β-catenin inactivation
As a result, 38 gene sets were commonly upregulated ( Figure 5A ) and 33 were commonly downregulated ( Figure Figure   5D ). These methyltransferases were arginine-specific Prmt1, Prmt5 and Prmt7.
Consistently, H4-R3 specific histone methyltransferase activity was amongst the enriched GO:Molecular functions ( Figure 5E , Dataset EV4D), suggesting that arginine methylation may be co-regulated by Hoxa9 and Ctnnb1. Indeed, when the targets of Hoxa9/Meis1 gene sets were overlapped with the synergistically up-and down-regulated genes, 19 out of 111 (17%) genes from the Hoxa9/Meis1 targets ( Figure 5F , Dataset EV4E), were synergistically regulated by β-catenin and Hoxa9 in LSK-MLL-ENL (χ 2 , p=1.4e-22). Moreover, among them is again Prmt1, which had also been independently confirmed by RT-qPCR ( Figure 5F ). Strikingly, Prmt1 is a key epigenetic modifying enzyme known to be recruited by various fusion proteins involved in AML pathogenesis (Cheung, Chan et al., 2007 , Cheung, Fung et al., 2016 , Shia, Okumura et al., 2012 , leading us to examine its role in mediating β-catenin/Hoxa9 functions in LSK-MLL-ENL cells. , Huntly et al., 2004 , So et al., 2003 , which exhibit different responses to standard chemotherapy treatment (George, Uyar et al., 2016 , Krivtsov et al., 2013 , Stavropoulou et al., 2016 . Intriguingly, activation of canonical Wnt/β-catenin in MLL-CSCs has also recently been identified as a major mechanism for development of resistance to pharmacological inhibition of BET (Fong, Gilan et al., 2015 , Rathert, Roth et al., 2015 , a targeted therapy at its early clinical phase for MLL leukemia, further highlighting the importance of adequately targeting β-catenin in the context of cellsof-origin for future targeted cancer therapies. Given the challenges involved in developing clinically effective inhibitors to β-catenin (Fung et al., 2013) , the identification of Prmt1 as a nexus for mediating leukemic self-renewal in LSK-MLL-ENL transformed cells not only provides novel mechanistic insights into the downstream targets and molecular networks regulated by β-catenin, but also suggest an alternative avenue for targeting β-catenin in MLL-CSCs.
Material and Methods
Animals and transplantation studies
All experimental procedures were approved by King's College London ethics committees and conform to the UK Home Office regulations. For all in vivo experiments, mice were distributed into their respective groups randomly. Investigators were not blinded to the sample identity. Mice were considered leukemic when an engraftment of donor cell (>30%) was detected in the bone marrow. Ctnnb1 fl/fl mice (Brault et al., 2001) were crossed with Rosa26-CreER Rosa26-YFP mice to generate Ctnnb1 fl/fl RosaCre-ER RosaYFP mice. These mice were crossed with Hoxa9 -/-knockout mice (Smith et al., 2011 , So et al., 2004 to generate Hoxa9 -/-Ctnnb1 fl/fl RosaCre-ER RosaYFP mice. Compound homozygous animals were used for experiments. C57BL/6 or SJL mice were given 11Gy total body γ-irradiation and injected via tail vein with test cells mixed with C57BL/6 or SJL bone marrow nuclear cells. Mice were culled when sign of sickness appeared. Survival curves were produced using GraphPad Prism software, and survival differences tested with the log-rank test. For leukemia development experiments, up to 500,000 test cells mixed with 200,000 C57BL/6 or SJL bone marrow nuclear cells were transplanted. For primary transplants n=5-18 mice/cohort and for secondary transplants n=3-10 mice/cohort were used. For in vivo limiting dilution assays, varying numbers of cells from indicted populations were transplanted into n=5 sublethally irradiated syngeneic mice/cohort and monitored for disease development. ELDA was used for statistical analysis (Hu & Smyth, 2009 ). For in vivo homing experiments, 5 million test cells were transplanted into n≥4 (when studying genetic ablation) and n=2 (when studying shPRMT1 knockdown) sublethally irradiated syngeneic mice/cohort/time point. Homing differences were statistically tested using a two-tailed t-test in Excel.
Hematopoietic stem and progenitor purification
Mouse femur and tibias were prepared and c-kit+ (CD117) cells isolated (Zeisig & So, 2009) using MACS (Miltenyi Biotech Technology, Germany) . LSK and GMP populations were isolated as previously described (Yeung & So, 2009) . Briefly, LSK (lin-, Sca-1+, c-Kit+) and GMP (lin-, Sca-1-, c-Kit+, CD34+, CD16/32lo) were isolated from lineage negative cells after lineage (Gr-1, Mac-1, B220, Ter119, CD3e, CD4, CD8) (Biolegend/eBiosciences) depletion using a BD FACS ARIA cell sorter. Post-sort purity of greater than 97% was routinely achieved. For functional analysis, sorted LSK and GMP were plated in Methocult M3434 (Stem Cell Technologies, Canada) and after 7-10 days of incubation different colony types were scored.
Retroviral transduction and transformation (RTTA) assays
RTTA were performed as previously described with some modifications (Zeisig & So, 2009 ). The MSCV-MLL-ENL construct has been described previously. The two independent shRNAs against murine Prmt1 have been reported previously (Cheung et al., 2007) . Briefly, isolated c-Kit+, LSK or GMP cells were cultured overnight in RPMI+10%FBS supplemented with 20ng/ml SCF, 10ng/ml IL3 and 10ng/ml IL6 prior to viral transduction with virus particles carrying MLL-ENL by centrifugation at 800xg at 32C for 2hr. Cells were plated in M3234 Methylcellulose medium supplemented with 20ng/ml SCF, 10ng/ml of each IL3, IL6 and GM-CSF and appropriate antibiotic selection on the following day. Colonies were scored after 7 days and replated every 7 days. To induce the deletion of Ctnnb1, 20nM tamoxifen (Sigma, US) was added to the Methylcellulose medium in the second round of plating and YFP positive were sorted after the second round of plating using a BD FACS ARIA and plated into the 3 rd round. After the 4 th round of plating, cells were cultured in R20/20 to establish cell lines as previously described (Yeung et al., 2010) . Differences in colony numbers were statistically tested using a two-tailed t-test in Excel.
Phenotypic analysis
Immunophenotypic analysis was performed by FACS using fluorochrome-conjugated monoclonal antibodies to murine c-Kit (2B8 clone), Mac-1 (M1/70) and Gr-1 (RB6-8C5) (eBiosciences). Staining was generally performed on ice for 15mins and washed once before analysis using a BD LSR II system. Differences in surface marker expression were statistically tested using a two-tailed t-test in Excel.
Western blot
Cell lysates from primary transformed cells or sorted leukemic cells were isolated and subjected to western blot as described (Yeung et al., 2010) .
Histone extraction and detection
Histone proteins were prepared by acid extraction (Abcam protocol, http://www.abcam.com/protocols/histone-extraction-protocol-for-western-blot). Briefly, cells were lysed for 10 minutes on ice in TEB buffer (PBS/0.5%Triton X 100/protease inhibitors) at a cell density of 10 7 per ml. The nuclei were harvested by centrifugation, and washed in half the volume of TEB. Pellets were resuspended in 0.2N HCl at a density of 4x10 7 nuclei per ml and histones were extracted overnight at 4C. Samples were centrifuged to pellet debris and the supernatant containing the histones were transferred into a new Eppendorf tube. 10ul histones were mixed with 40ul PBS and 50ul 2xSDS loading buffer and incubated at 95C for 8minutes. 25ul of the denatured histones were subjected to western blot using a 10% Next gel (AMRESCO LLC). Antibodies against H4R3me2a (Active Motif) and Histone H3 (Abcam) were used.
Genotyping PCR
Genomic DNA was isolated and β-catenin genotyping PCR was performed as described previously (Brault et al., 2001) . Primer sequences for Hoxa9 are available on request. Differences in gene expression were statistically tested using a two-tailed t-test in Microsoft Excel.
q-RT-PCR
q-RT-PCR was performed on StepOne qPCR machine (Applied Biosystems) using Taqman or SYBR green chemistries. See Appendix Table S1 for the primer sequences used throughout the paper for validation.
Apoptosis and cell cycle analysis
MLL-ENL transduced Hoxa9
-/-
Ctnnb1
fl/fl cells were treated for 72hours with or without tamoxifen and stained with AnnexinV for apoptosis. Cell cycle was analyzed using the BRDU Flow kit (BD Pharmingen) according to manufacturer's instructions. Cells were analyzed using a BD LSR II system (BD, USA) and differences were statistically tested using a two-tailed t-test in Excel.
RNA sequencing
300ng to 1ug of mirVANA (Ambion) isolated total RNA was used for RNA-Seq library preparation using TruSeq Stranded Total RNA kit (Illumina) and sequenced on HIseq2000 platform (Illumina) as per manufacturers recommendations. All samples are listed in Dataset EV1A.
Whole genome sequencing
Genomic DNA was isolated with the QIAamp DNA Micro kit (Qiagen) according to the manufacturer's instructions, and 30ng of genomic DNA was used as input for each library preparation. Whole-genome sequencing libraries were generated using the tagmentation method as previously described (Wang, Gu et al., 2013) , but without bisulfite treatment and with minor modifications. Briefly, genomic DNA was subjected to tagmentation with a hyperactive Tn5 transposase (Epizyme), which fragmented the DNA and appended sequencing adaptors in a single step. After PCR amplification of libraries, DNA fragments of 200-800bp were double-side selected using SPRI Ampure XP beads, with left-right ratios of 1.5-0.55. Purified libraries were subjected to 125-bp paired-end sequencing on an Illumina HiSeq2500 machine.
Bioinformatic analyses
Mapping and read counts
The FASTQ files were de-tagged, and the quality of the FASTQ files inspected using FastQC v.0.11.2 (Andrews, 2015) . Remaining adapters were trimmed using TRIMGalore! v.0.3.7 (Kreuger, 2015) . Whole genome sequencing reads were mapped to the Ensembl mouse genome GRCm38 (Aken, Ayling et al., 2016 ) using Bowtie2 v.2.2.5 (Langmead & Salzberg, 2012) . RNA-Seq reads were mapped to the Ensembl mouse genome using TopHat2 v2.0.13 (Kim, Pertea et al., 2013) , reads were filtered for quality and counted using samtools v.0.1.18 and bedtools v2.23.0-10-g447cb97 (Li, Handsaker et al., 2009 , Quinlan & Hall, 2010 ) (Dataset EV1B).
SNP calling
SNP calling (for both RNA-Seq and WGS) was performed using samtools v.0.1.18 mpileup and bcftools v.1.2 (using htslib v.1.2.1) (Li, 2011) , SNPs were leniently filtered only for quality >=Q30, and custom scripts used to produce summary stats (Dataset EV1C). To summarize the regions in which SNPs fell, variant call files and Ensembl GTF annotation (Mus_musculus.GRCm38.82.gtf) were converted to bed format using custom scripts and compared using bedtools intersect v2.23.0. Bedtools complement v2.23.0 (Quinlan & Hall, 2010) was used to extract intronic and intergenic coordinates.
Gene differential expression
Differential expression was determined either using DESeq2 v.1.10.1 (Love, Huber et al., 2014) , negative binomial GLM fitting and Wald statistics; or with limma v.3.26.9 (Ritchie, Phipson et al., 2015) using voom to normalize read counts, and eBayes to determine differential expression (as detailed in Expanded View Datasets). Functional enrichment analysis was conducted using the GSEA software, using various Molecular Signature Databases (c2 set version 5.0, version 6.0 and all_gene_sets) (MSigDB) (Subramanian, Tamayo et al., 2005) appended with a custom made gene set for LSC stem cell maintenance (Somervaille et al., 2009 ) (Dataset EV3B), comparing log2-fold changes in gene expression as the ranking metric. For the GSEA analysis, human-mouse gene orthologues were identified using MGI list of orthologous genes (Blake, Bult et al., 2014) , and Ensembl bioMart used to transfer MGI IDs to Ensembl gene IDs (Kinsella, Kahari et al., 2011) . In order to find genes which showed a synergistic effect of simultaneous knockout of Cbnnt1 and Hoxa9, differential expression was tested with DESeq2 Negative Binomial GLM fitting and Wald statistics. The data was subjected to five DE analyses, which served to categorize the genes into 78 different classes. These comparisons are 1. LSK WT to Ctnnb1 KO, 2. LSK WT to HoxA9 KO, 3. Additive effect LSK WT to Ctnnb1 KO and Hoxa9 KO, 4. LSK Ctnnb1 KO to Ctnnb1:HoxA9 interaction, 5. LSK HoxA9 KO to Ctnnb1:HoxA9 interaction. For overlapping significantly differentially expressed genes, heatmaps were plotted using the function heatmap.2 from the R-package gplots v3.0.1 (Warnes, Bolker et al., 2016) with Z-score scaling of rows and/or columns.
Survival analysis
Statistical analysis and data visualization was performed using R (R Core Team, 2014) . Survival and Cox proportional hazards ratio analysis was conducted using Rpackages survival v.2.39.5 (Therneau, 2015) and survcomp v.1.20.0 (Schroder, Culhane et al., 2011 ) on all patients which had complete survival and expression data from the following datasets; GSE1159 (n=293), GSE12417; GPL570 (n=79), GPL96 (n=163), GSE14468 + GSE6891 (n=602), GSE5122 (n=58), GSE8970 (n=34) available from the Gene Expression Omnibus database ncbi.nlm.nih.gov/geo/ and The Cancer Genome Atlas AML dataset (n=183) (Cancer Genome Atlas Research, 2013) . Summary data for patient cohorts are presented in Dataset EV2D. Samples were normalized using the GENENORM algorithm from the R-package inSilicoMerging v.1.15.0 (Taminau, Meganck et al., 2012) with prior DESeq2 Vst transformation of RNA-Seq samples used in this study to derive the cell-of-origin specific signature (Love et al., 2014) . All probe intensities were translated into human genes and averaged prior to merging. MLL patients in the datasets were identified from associated karyotyping and PCR diagnosis.
Data availability
All WGS has been submitted to the ENA study PRJEB14461. RNA-Seq is available on ArrayExpress E-MTAB-3647.
Statistical analysis
All the experimental results were analysed using two-tailed Student's t-test, χ2 test, hypergeometric test, as indicated in the figure legends and Expanded View Datasets. Groups that were statistically compared shared a similar variance, as shown in the figures. P<0.05 was considered as statistically significant. For GSEA analysis, FDR-q values <0.25 were considered as statistically significant (Subramanian et al., 2005) . The log-rank test was used to compare survival curves. (Hess et al., 2006) , "LSC_mainentence_down" (Somervaille et al., 2009) , "Hoxa9/Meis1_UP" (Hess et al., 2006) and "LSC_maintenance_up" (Somervaille et al., 2009 ) as indicated. (C) A small set of genes is synergistically regulated by β-catenin and Hoxa9 (the effect of knockout of both genes is smaller or larger than could have been predicted from their single knockouts). Example sets of genes synergistic up-regulated (top), down-regulated (bottom) and non-significantly regulated (bottom right) are shown (all sets are in Figure S5 
